Search research articles
Contact Us
Filters
Showing results (151-160 of 171) with videos related to
Page
of 18
Sort By:
Science Translational Medicine
|
September 20, 2023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
Gongwei Wu, Noriaki Yoshida, Jihe Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2016
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016
Steven M Horwitz, Andrew D Zelenetz, Leo I Gordon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2017
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017
William G Wierda, Andrew D Zelenetz, Leo I Gordon, et al.
American Journal of Hematology
|
June 13, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma
Alyssa Bouska, Weiwei Zhang, Sunandini Sharma, et al.
Journal of the American Heart Association
|
October 17, 2022
Tachyarrhythmias During Hospitalization for COVID-19 or Multisystem Inflammatory Syndrome in Children and Adolescents
Audrey Dionne, Kevin G Friedman, Cameron C Young, et al.
Nature Communications
|
May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
Samuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
JAMA Neurology
|
November 7, 2022
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020
Kerri L LaRovere, Tina Y Poussaint, Cameron C Young, et al.
The New England Journal of Medicine
|
June 16, 2021
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes
Mary Beth F Son, Nancy Murray, Kevin Friedman, et al.
The New England Journal of Medicine
|
June 30, 2020
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
Leora R Feldstein, Erica B Rose, Steven M Horwitz, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 171) with videos related to
Sort By:
Page
of 18
Science Translational Medicine
|
September 20, 2023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
Gongwei Wu, Noriaki Yoshida, Jihe Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 3, 2016
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016
Steven M Horwitz, Andrew D Zelenetz, Leo I Gordon, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 10, 2017
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017
William G Wierda, Andrew D Zelenetz, Leo I Gordon, et al.
American Journal of Hematology
|
June 13, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma
Alyssa Bouska, Weiwei Zhang, Sunandini Sharma, et al.
Journal of the American Heart Association
|
October 17, 2022
Tachyarrhythmias During Hospitalization for COVID-19 or Multisystem Inflammatory Syndrome in Children and Adolescents
Audrey Dionne, Kevin G Friedman, Cameron C Young, et al.
Nature Communications
|
May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
Samuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
JAMA Neurology
|
November 7, 2022
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020
Kerri L LaRovere, Tina Y Poussaint, Cameron C Young, et al.
The New England Journal of Medicine
|
June 16, 2021
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes
Mary Beth F Son, Nancy Murray, Kevin Friedman, et al.
The New England Journal of Medicine
|
June 30, 2020
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
Leora R Feldstein, Erica B Rose, Steven M Horwitz, et al.
Page
of 18